Evaluation of Institutional Review Board review and informed consent in publications of human research in critical care medicine

机构审查委员会 医学 知情同意 家庭医学 心理干预 替代医学 梅德林 临床研究 法学 护理部 精神科 内科学 病理 政治学
作者
Idit Matot,Reuven Pizov,Charles L. Sprung
出处
期刊:Critical Care Medicine [Ovid Technologies (Wolters Kluwer)]
卷期号:26 (9): 1596-1602 被引量:46
标识
DOI:10.1097/00003246-199809000-00035
摘要

Objective To examine the frequency of obtaining Institutional Review Board (IRB) approval and informed consent in critical care research. Data Sources and Data Extraction One-year retrospective review of original critical care research in humans published in seven journals, including American Journal of Respiratory and Critical Care Medicine, Chest, Critical Care Medicine, Intensive Care Medicine, The Journal of the American Medical Association, Lancet, and The New England Journal of Medicine. Studies were examined for general information (country/state where the research was performed, affiliation of the hospital to a medical school, and whether the work was supported by a grant and specifically by a pharmaceutical company), approval by IRB, method of consent, design of research, and interventions involved in the study. Data Synthesis Two hundred seventy-nine studies were reviewed, 124 (44%) of which were conducted in the United States. Two hundred forty-three (87%) studies were performed in a university institution, 96 (34%) studies were supported by a grant, and 23 (24%) studies were supported by a pharmaceutical company. In 66 (24%) studies, there was no evidence of IRB review and informed consent approval. IRB approval was obtained but the method of consent was not specified in 36 (13%) studies. No significant differences were found in obtaining IRB approval and informed consent between research conducted in the United States (n = 71, 57%) or outside the United States (n = 92, 59%). Grant support was obtained in ten (9%) of the 116 studies not fully approved, compared with 70 (50%) of the 140 studies that obtained full approval (p<.05). All studies (23) supported by the pharmaceutical industry were fully approved. Conclusions Many published studies in critical care lack IRB approval and/or informed consent. All research supported by the pharmaceutical industry was fully approved. The findings raise ethical concerns about critical care research. (Crit Care Med 1998; 26:1596-1602)

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
lvxsit完成签到,获得积分10
刚刚
wanci应助Qi采纳,获得10
1秒前
1秒前
1秒前
zz完成签到 ,获得积分10
1秒前
深情安青应助科研小白采纳,获得10
2秒前
Singularity应助胺碘酮采纳,获得20
2秒前
4秒前
夏日生生豪完成签到 ,获得积分10
5秒前
5秒前
烟花应助学术安陵容采纳,获得10
6秒前
自由青柏发布了新的文献求助10
7秒前
蛋黄派完成签到,获得积分10
7秒前
xiaotu完成签到,获得积分10
7秒前
隐形曼青应助健忘的南风采纳,获得10
9秒前
godsence发布了新的文献求助10
9秒前
星星草发布了新的文献求助10
9秒前
独钓者梁发布了新的文献求助10
11秒前
12秒前
13秒前
13秒前
13秒前
星辰大海应助独孤刘采纳,获得10
15秒前
英俊的铭应助godsence采纳,获得10
15秒前
lzy完成签到 ,获得积分10
15秒前
笨笨从凝发布了新的文献求助10
16秒前
李大伟完成签到,获得积分10
17秒前
研友_85rWQL发布了新的文献求助10
17秒前
宸1发布了新的文献求助10
17秒前
18秒前
大宝发布了新的文献求助10
18秒前
18秒前
桐桐应助Kumple采纳,获得10
19秒前
酷波er应助KEEP采纳,获得10
20秒前
ZHOUJING发布了新的文献求助10
20秒前
独钓者梁完成签到,获得积分10
20秒前
tizi发布了新的文献求助30
23秒前
神内小钟完成签到,获得积分10
23秒前
邢慧兰发布了新的文献求助10
25秒前
27秒前
高分求助中
Evolution 10000
Sustainability in Tides Chemistry 2800
юрские динозавры восточного забайкалья 800
Diagnostic immunohistochemistry : theranostic and genomic applications 6th Edition 500
Chen Hansheng: China’s Last Romantic Revolutionary 500
China's Relations With Japan 1945-83: The Role of Liao Chengzhi 400
Classics in Total Synthesis IV 400
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3150257
求助须知:如何正确求助?哪些是违规求助? 2801405
关于积分的说明 7844390
捐赠科研通 2458892
什么是DOI,文献DOI怎么找? 1308773
科研通“疑难数据库(出版商)”最低求助积分说明 628562
版权声明 601721